Interview with Philippe Ranty, Managing Director, Actavis France
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
Address: Centre d’Affaires la Boursidière BP 50, 92357 le Plessis-Robinson, France ,France
Tel: +33 1 40 83 77 77
Web: http://www.actavis.com/en/default.htm
Actavis is the fifth largest generics company worldwide. In France, Actavis has been present since acquiring Labo Torlan in 2007. The groups domestic strategy can be characterized by three elements: a large product offer, a new approach of quality and customer relationship management and a strong involvement in sustainable development.
Actavis serves the French market through its Actavis France, Arrow Generiques and Medis businesses. The Company develops, manufactures and distributes a broad portfolio of products, including generic drugs for retail and hospital markets, OTC, cosmetics and mature products.
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the French model rewards innovative…
The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the market. Can you explain…
What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them? The main idea is that…
See our Cookie Privacy Policy Here
